Home › Funds › Private Capital Management, LLC › LGND

Private Capital Management, LLC position in LGND

LIGAND PHARMACEUTICALS INC · Health Care

Private Capital Management, LLC reported holding 166,016 shares of LGND (LIGAND PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$52.5M, representing 5.04% of its reported portfolio and ranking #3 among its reported holdings. Private Capital Management, LLC has disclosed LGND holdings in 9 of the last 9 reported quarters, going back to Q2 2024.

Latest position (Q2 2026)166.02K sh
Reported value held$52.48M
Portfolio Weight5.04%
First reportedQ2 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Private Capital Management, LLC's LGND position evolved

Private Capital Management, LLC first disclosed a stake in LGND in Q2 2024 at 134,505 shares (US$11.3M). The position peaked in Q2 2026 at 166,016 shares, worth US$52.5M. Across 9 filings, Private Capital Management, LLC increased the stake 2 time(s), trimmed it 4 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 166,016 shares valued at US$52.5M — a reduction of -35,365 shares quarter over quarter.. Notable position changes include a 55% increase in Q2 2025 (shares rose 56% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 134.50K $11.33M New
Q3 2024 133.88K $13.40M Hold
Q4 2024 133.69K $14.32M Hold
Q1 2025 148.12K $15.54M Add
Q2 2025 229.25K $26.06M Add
Q3 2025 227.16K $40.24M Reduce
Q4 2025 208.89K $39.50M Reduce
Q1 2026 201.38K $40.21M Reduce
Q2 2026 166.02K $52.48M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LGND and 13F data

LGND (LIGAND PHARMACEUTICALS INC) is a Health Care company. 57 other funds we track also report a position in LGND — the largest reported positions include CONGRESS ASSET MANAGEMENT CO (US$205.7M), Chicago Capital, LLC (US$172.2M), Stephens Investment Management Group LLC (US$150.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LGND

All LGND fund holders →

FAQ

How long has Private Capital Management, LLC held LGND?

Private Capital Management, LLC has disclosed LGND holdings in 9 of the last 9 reported quarters, going back to Q2 2024.

What is Private Capital Management, LLC's current position in LGND?

As of Q2 2026, Private Capital Management, LLC holds 166.02K shares of LGND (LIGAND PHARMACEUTICALS INC), valued at $52.48M, representing 5.04% of its reported portfolio and ranking #3.

Has Private Capital Management, LLC been buying or selling LGND?

In the latest 13F filing (Q2 2026), Private Capital Management, LLC reduced its position in LGND. The position peaked in Q2 2026 at 166.02K shares.

Which other funds hold LGND?

Other major institutional holders of LGND include CONGRESS ASSET MANAGEMENT CO, Chicago Capital, LLC, Stephens Investment Management Group LLC, among 57 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.